Io Biotech Inc (IOBT)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
IO Biotech*s Phase 2 Trial Empowers the Immune System to Combat Solid Tumors
Major Pharmaceutical Prep Company Battling $-23.484M Operating Deficit, Struggling in Q3 2023
Io Biotech Inc. Faces Challenging Start to 2023 with Operating Shortfall of $-17.924 Million
declared operating shortfall in the second quarter of 2022
Working expenditures have been increasing at the in the third quarter of 2022